NurExone Biologic Inc. — Form D

NurExone Biologic Inc. of TECHNION CITY, HAIFA, L3, a company, filed a Form D exempt-offering notice with the SEC on 2025-08-27. The offering totals $243K, of which $148K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2025-08-27
• Form: D
• Accession: 0001062993-25-014970
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $243K
• Amount sold: $148K
• Remaining: $95K
• Investors: 1
• Date of first sale: 2025-08-20
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-555963

Issuer

• Name: NurExone Biologic Inc.
• CIK: 0001995074
• Entity type: Corporation
• Jurisdiction: ONTARIO, CANADA
• Incorporated: 2025
• Address: MINUS 1 ENTRY, GROUND FLOOR OF BLDG B GUTWIRTH INDUSTRIAL PARK, TECHNION CITY, HAIFA, L3, 3200003
• Phone: 972 52-4803034

Officers, directors & promoters (15)

Other filings by this issuer (9)

More

• CIK 1995074 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search